{
  "drug_name": "Norfloxacin",
  "usage_and_dosing": {
    "general": [
      "Norfloxacin is one of the early fluoroquinolones.",
      "Indications for use overlap with those of Ciprofloxacin and Levofloxacin. As Ciprofloxacin and Levofloxacin have a greater degree of antibacterial activity and as both are now available in generic form, the use of Norfloxacin has decreased.",
      "Caution: numerous drug interactions (see chart below, not all-inclusive).",
      "No longer available in the US."
    ],
    "adult_dose": {
      "enterocolitis_due_to_shigella": "400 mg po bid x 5 days",
      "prostatitis_due_to_susceptible_aerobic_gram_negative_bacillus": "400 mg po bid x 4-6 weeks",
      "travelers_diarrhea_due_to_toxigenic_e_coli": "400 mg po bid x 3 days",
      "uncomplicated_female_non_gonococcal_urethritis_cystitis": "400 mg po bid x 3 days",
      "prophylaxis_in_cirrhotic_patients_with_bleeding_from_esophageal_varices": "400 mg po bid x maximum of 7 days"
    },
    "pediatric_dose": {
      "dose_age_gt_28_days": "Safety and efficacy not established",
      "max_day": "-"
    }
  },
  "renal_adjustment": {
    "half_life_normal": "3-4",
    "half_life_esrd": "8",
    "dose_renal_function_normal": "400 mg po q12h",
    "crcl_or_egfr": "CrCl >50: No dosage adjustment. CrCl 30-49: 400 mg q12h. CrCl 10-30: 400 mg q24h",
    "hemodialysis": "400 mg q24h",
    "capd": "400 mg q24h",
    "crrt": "Not applicable",
    "sled": "No data"
  },
  "hepatic_adjustment": {
    "mild_impairment_child_pugh_a": "No dosage adjustment",
    "moderate_impairment_child_pugh_b": "No dosage adjustment",
    "severe_impairment_child_pugh_c": "No dosage adjustment"
  },
  "adverse_effects": [
    "Poorly understood CNS toxicity that varies from lightheadedness to confusion and rarely to seizures.",
    "Prolongation of the corrected QT interval; risk increases with hypokalemia, hypomagnesemia and concomitant use of other drugs with the potential for prolongation of the QT interval.",
    "Gastrointestinal intolerance: nausea and vomiting.",
    "Tendinopathy: spontaneous tendon rupture. Risk is highest with concomitant use of corticosteroids.",
    "Chelation of drug by multivalent cations (calcium, magnesium, aluminum, iron) in dairy food, multivitamins, or antacids. Result is failure to absorb the drug.",
    "Allergic reactions are rare.",
    "Rare increase in muscle weakness in patients with myasthenia gravis.",
    "Photosensitivity can occur."
  ],
  "antimicrobial_spectrum": {
    "preferred": [],
    "alternative": []
  },
  "pharmacology": {
    "pk_pd_index": "24-hr AUC/MIC",
    "preparations": "Tab (400 mg)",
    "food_recommendation": "Tab no food",
    "oral_absorption_percent": "30-40",
    "tmax_hr": "1",
    "peak_serum_conc_ug_ml": "1.5 (400 mg po, SD)",
    "peak_urine_conc_ug_ml": "No data",
    "protein_binding_percent": "10-15",
    "volume_of_distribution_vd_l_kg": "1.7 L/kg",
    "avg_serum_half_life_hr": "3-4",
    "elimination": "Metabolized, biliary, renal",
    "bile_penetration_percent": "700",
    "csf_blood_percent": "No data",
    "therapeutic_levels_in_csf": "No",
    "auc_ug_hr_ml": "6.4 (400 mg po, 0-inf)"
  },
  "enzyme_transporter_mediated_interactions": {
      "cyp450s_substrate": [],
      "transporters_substrate": [],
      "ugts_substrate": [],
      "cyp450s_inhibited": ["CYP1A2 (weak)"],
      "transporters_inhibited": [],
      "ugts_inhibited": [],
      "cyp450s_induced": [],
      "transporters_induced": [],
      "ugts_induced": [],
      "impact_on_serum_drug_concentrations": "mild ↑"
  },
  "major_drug_interactions": [
      {"drug": "Antacids (Al, Ca, Mg)", "effect": "↓ norfloxacin", "management": "Separate administration by 2 hours"},
      {"drug": "Antiarrhythmics (Class IA/III)", "effect": "↑ QT interval", "management": "Avoid co-administration"},
      {"drug": "Caffeine", "effect": "↑ caffeine", "management": "Monitor, adjust dosage"},
      {"drug": "Calcium supplements", "effect": "↓ norfloxacin", "management": "Separate administration by 2 hours"},
      {"drug": "Clozapine", "effect": "↑ clozapine", "management": "Monitor, adjust dosage"},
      {"drug": "Cyclosporine", "effect": "↑ cyclosporine", "management": "Monitor, adjust dosage"},
      {"drug": "Didanosine", "effect": "↓ norfloxacin", "management": "Separate administration by 2 hours"},
      {"drug": "Duloxetine", "effect": "↑ duloxetine", "management": "Monitor or avoid"},
      {"drug": "Insulin", "effect": "↑↓ blood glucose", "management": "Monitor"},
      {"drug": "Iron supplements", "effect": "↓ norfloxacin", "management": "Separate administration by 2 hours"},
      {"drug": "NSAIDS", "effect": "↑ risk of CNS stimulation/seizures", "management": "Monitor or avoid"},
      {"drug": "Oral hypoglycemics", "effect": "↑↓ blood glucose", "management": "Monitor"},
      {"drug": "Probenecid", "effect": "↑ norfloxacin", "management": "Monitor or avoid"},
      {"drug": "Sucralfate", "effect": "↓ norfloxacin", "management": "Separate administration by 2 hours"},
      {"drug": "Theophylline", "effect": "↑ theophylline", "management": "Monitor or avoid"},
      {"drug": "Tizanidine", "effect": "↑ tizanidine", "management": "Contraindicated"},
      {"drug": "Warfarin", "effect": "↑ warfarin, ↑ INR", "management": "Monitor INR, adjust dosage"},
      {"drug": "Zinc", "effect": "↓ norfloxacin", "management": "Separate administration by 2 hours"}
  ]
}
